Weitere Artikel dieser Ausgabe durch Wischen aufrufen
The online version of this article (https://doi.org/10.1007/s11136-018-2037-7) contains supplementary material, which is available to authorized users.
The current study aims to map the Positive and Negative Syndrome Scale (PANSS) onto the five-level EuroQol five-dimensional (EQ-5D-5L) and Short Form six-dimensional (SF-6D) utility scores for patients with schizophrenia.
A total of 239 participants with schizophrenia spectrum disorder were recruited from a tertiary psychiatric hospital in Singapore. Ordinary least squares (OLS), censored least absolute deviations and Tobit regression methods were employed to estimate utility scores from the EQ-5D-5L and SF-6D. Model selection of the 18 regression models (three regression methods × six model specifications) was primarily determined by the smallest mean absolute error and mean square error, and the largest R2 and adjusted R2.
The mean age of the sample was 39.7 years (SD = 10.3). The mean EQ-5D-5L and SF-6D utility scores were 0.81 and 0.68, respectively. The EQ-5D-5L utility scores were best predicted by the OLS regression model consisting of three PANSS subscales, i.e. positive, negative and general psychopathology symptoms, and covariates including age and gender. The SF-6D was best predicted by OLS regression model consisting of five PANSS subscales, i.e. positive, negative, excitement, depression and cognitive subscales.
The current study provides important evidence to clinicians and researchers on mapping algorithms for converting PANSS scores into utility scores that can be easily applicable for cost–utility analysis when EQ-5D-5L and SF-6D data are not available for patients with schizophrenia spectrum disorder in Singapore.
Supplementary material 1 (DOCX 37 KB)11136_2018_2037_MOESM1_ESM.docx
WHO. (1998). Schizophrenia and public health. Division of mental health and prevention of substance abuse, Geneva: World Health Organization.
Andrew, A., Knapp, M., McCrone, P., et al. (2012). Effective interventions in schizophrenia: The economic case, in personal social services research unit. London: London School of Economics and Political Science.
Brazier, J. (2008). Measuring and valuing mental health for use in economic evaluation. The Journal of Health Services Research & Policy, 13(Suppl 3), 70–75. CrossRef
Brazier, J., Connell, J., Papaioannou, D., et al. (2014). A systematic review, psychometric analysis and qualitative assessment of generic preference-based measures of health in mental health populations and the estimation of mapping functions from widely used specific measures. Health Technology Assessment, 18, 1–188. CrossRef
NICE. (2013). Guide to the methods of technology appraisal 2013, National Institute for Health and Care Excellence, UK. https://www.nice.org.uk/process/pmg9/chapter/foreword.
Longworth, L., Yang, Y., Young, T., et al. (2014). Use of generic and condition-specific measures of health-related quality of life in NICE decision-making: A systematic review, statistical modelling and survey. Health Technology Assessment, 18, 1–224. CrossRef
Brazier, J. E., Yang, Y., Tsuchiya, A., et al. (2010). A review of studies mapping (or cross walking) non-preference based measures of health to generic preference-based measures. The European Journal of Health Economics, 11, 215–225. CrossRef
Dakin, H., Abel, L., Burns, R., et al. (2018). Review and critical appraisal of studies mapping from quality of life or clinical measures to EQ-5D: An online database and application of the MAPS statement. Health and Quality of Life Outcomes, 16, 31. CrossRef
Siani, C., de Peretti, C., Millier, A., et al. (2016). Predictive models to estimate utility from clinical questionnaires in schizophrenia: Findings from EuroSC. Quality of Life Research, 25, 925–934. CrossRef
Kay, S. R., Fiszbein, A., & Opler, L. A. (1987). The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bulletin, 13, 261–276. CrossRef
Jiang, J., Sim, K., & Lee, J. (2013). Validated five-factor model of positive and negative syndrome scale for schizophrenia in Chinese population. Schizophrenia Research, 143, 38–43. CrossRef
Singapore Department of Statistics. (2017). Yearbook of statistics Singapore, 2017. Singapore: Ministry of Trade & Industry.
van Hout, B., Janssen, M. F., Feng, Y. S., et al. (2012). Interim scoring for the EQ-5D-5L: Mapping the EQ-5D-5L to EQ-5D-3L value sets. Value in Health, 15, 708–715. CrossRef
Brazier, J., Roberts, J., & Deverill, M. (2002). The estimation of a preference-based measure of health from the SF-36. Journal of Health Economics, 21, 271–292. CrossRef
Wee, H. L., Cheung, Y. B., Fong, K. Y., et al. (2004). Are English- and Chinese-language versions of the SF-6D equivalent? A comparison from a population-based study. Clinical Therapeutics, 26, 1137–1148. CrossRef
Xie, F., Pullenayegum, E. M., Li, S. C., et al. (2010). Use of a disease-specific instrument in economic evaluations: Mapping WOMAC onto the EQ-5D utility index. Value in Health, 13, 873–878. CrossRef
Powell, J. L. (1984). Least absolute deviations estimation for the censored regression model. Journal of Econometrics, 25, 303–325. CrossRef
Tobin, J. (1985). Estimation of relationships for limited dependent variables. Econometrica, 26, 24–36. CrossRef
Payakachat, N., Summers, K. H., Pleil, A. M., et al. (2009). Predicting EQ-5D utility scores from the 25-item National Eye Institute Vision Function Questionnaire (NEI-VFQ 25) in patients with age-related macular degeneration. Quality of Life Research, 18, 801–813. CrossRef
Subramaniam, M., Abdin, E., Poon, L. Y., et al. (2014). EQ-5D as a measure of programme outcome: Results from the Singapore early psychosis intervention programme. Psychiatry Research, 215, 46–51. CrossRef
Subramaniam, M., Abdin, E., Vaingankar, J. A., et al. (2013). Impact of psychiatric disorders and chronic physical conditions on health-related quality of life: Singapore Mental Health Study. Journal of Affective Disorders, 147, 325–330. CrossRef
Cheung, Y. B., Luo, N., Ng, R., et al. (2014). Mapping the functional assessment of cancer therapy-breast (FACT-B) to the 5-level EuroQoL Group’s 5-dimension questionnaire (EQ-5D-5L) utility index in a multi-ethnic Asian population. Health and Quality of Life Outcomes, 12, 180. CrossRef
Wijeysundera, H. C., Tomlinson, A. J., Norris, C. M., et al. (2011). Predicting EQ-5D utility scores from the Seattle Angina Questionnaire in Coronary Artery Disease: A mapping algorithm using a bayesian framework. Medical Decision Making, 31, 481. CrossRef
Austin, P. C. (2002). A comparison of methods for analyzing health-related quality-of-life measures. Value in Health, 5, 329–337. CrossRef
Pullenayegum, E. M., Tarride, J. E., Xie, F., et al. (2010). Analysis of health utility data when some subjects attain the upper bound of 1: Are Tobit and CLAD Models appropriate? Value in Health, 13, 487–494. CrossRef
Baum, C. F. (2006). An introduction to modern econometrics using stata. College Station: A Stata Press Publication.
Sullivan, P. W., & Ghushchyan, V. (2006). Mapping the EQ-5D index from the SF-12: US general population preferences in a nationally representative sample. Medical Decision Making, 26, 401–409. CrossRef
Chuang, L. H., & Kind, P. (2009). Converting the SF-12 into the EQ-5D: An empirical comparison of methodologies. Pharmacoeconomics, 27, 491–505. CrossRef
Cheung, Y. B., Tan, L. C., Lau, P. N., et al. (2008). Mapping the eight-item Parkinson’s Disease Questionnaire (PDQ-8) to the EQ-5D utility index. Quality of Life Research, 17, 1173–1181. CrossRef
Wang, P., Luo, N., Tai, E. S., et al. (2016). The EQ-5D-5L is more discriminative than the EQ-5D-3L in patients with diabetes in Singapore. Value in Health Regional Issues, 9, 57–62. CrossRef
Wailoo, A. J., Hernandez-Alava, M., Manca, A., et al. (2017). Mapping to estimate health-state utility from non-preference-based outcome measures: An ISPOR good practices for outcomes research task force report. Value in Health, 20, 18–27. CrossRef
Verma, S., Poon, L. Y., Subramaniam, M., et al. (2012). The Singapore Early Psychosis Intervention Programme (EPIP): A programme evaluation. The Asian Journal of Psychiatry, 5, 63–67. CrossRef
Verma, S., Subramaniam, M., Abdin, E., et al. (2010). Safety and efficacy of long-acting injectable risperidone in patients with schizophrenia spectrum disorders: A 6-month open-lable trial in Asian patients. Human Psychopharmacology, 25, 230–235. CrossRef
- Mapping the Positive and Negative Syndrome Scale scores to EQ-5D-5L and SF-6D utility scores in patients with schizophrenia
Siow Ann Chong
Kelvin Bryan Tan
- Springer International Publishing
Quality of Life Research
An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation - Official Journal of the International Society of Quality of Life Research
Print ISSN: 0962-9343
Elektronische ISSN: 1573-2649
Neuer Inhalt/© Stellmach, Neuer Inhalt/© BBL, Neuer Inhalt/© Maturus, Pluta Logo/© Pluta, Neuer Inhalt/© hww, Voraussetzungen für wirtschaftliche additive Fertigung/© Marco2811 | Fotolia